| UniProt ID | NOB1_HUMAN | |
|---|---|---|
| UniProt AC | Q9ULX3 | |
| Protein Name | RNA-binding protein NOB1 | |
| Gene Name | NOB1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 412 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | May play a role in mRNA degradation.. | |
| Protein Sequence | MAPVEHVVADAGAFLRHAALQDIGKNIYTIREVVTEIRDKATRRRLAVLPYELRFKEPLPEYVRLVTEFSKKTGDYPSLSATDIQVLALTYQLEAEFVGVSHLKQEPQKVKVSSSIQHPETPLHISGFHLPYKPKPPQETEKGHSACEPENLEFSSFMFWRNPLPNIDHELQELLIDRGEDVPSEEEEEEENGFEDRKDDSDDDGGGWITPSNIKQIQQELEQCDVPEDVRVGCLTTDFAMQNVLLQMGLHVLAVNGMLIREARSYILRCHGCFKTTSDMSRVFCSHCGNKTLKKVSVTVSDDGTLHMHFSRNPKVLNPRGLRYSLPTPKGGKYAINPHLTEDQRFPQLRLSQKARQKTNVFAPDYIAGVSPFVENDISSRSATLQVRDSTLGAGRRRLNPNASRKKFVKKR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 25 | Ubiquitination | AALQDIGKNIYTIRE HHHHHHHHHCEEHHH | 40.27 | 21906983 | |
| 29 | Phosphorylation | DIGKNIYTIREVVTE HHHHHCEEHHHHHHH | 15.12 | 24719451 | |
| 35 | Phosphorylation | YTIREVVTEIRDKAT EEHHHHHHHHHHHHH | 30.76 | - | |
| 35 | Ubiquitination | YTIREVVTEIRDKAT EEHHHHHHHHHHHHH | 30.76 | 21890473 | |
| 40 | Ubiquitination | VVTEIRDKATRRRLA HHHHHHHHHHHHHEE | 41.63 | - | |
| 42 | Phosphorylation | TEIRDKATRRRLAVL HHHHHHHHHHHEEEC | 30.37 | - | |
| 51 | Phosphorylation | RRLAVLPYELRFKEP HHEEECCEEEECCCC | 24.35 | 28152594 | |
| 56 | Ubiquitination | LPYELRFKEPLPEYV CCEEEECCCCCHHHH | 52.57 | 27667366 | |
| 62 | Phosphorylation | FKEPLPEYVRLVTEF CCCCCHHHHHHHHHH | 6.74 | 21406692 | |
| 71 | Ubiquitination | RLVTEFSKKTGDYPS HHHHHHHHHHCCCCC | 60.73 | 29967540 | |
| 71 | Acetylation | RLVTEFSKKTGDYPS HHHHHHHHHHCCCCC | 60.73 | 25953088 | |
| 72 | Ubiquitination | LVTEFSKKTGDYPSL HHHHHHHHHCCCCCC | 57.45 | - | |
| 111 | Ubiquitination | KQEPQKVKVSSSIQH CCCCCEEEEECCCCC | 43.36 | 29967540 | |
| 121 | Phosphorylation | SSIQHPETPLHISGF CCCCCCCCCCEECEE | 35.28 | 25159151 | |
| 126 | Phosphorylation | PETPLHISGFHLPYK CCCCCEECEECCCCC | 25.34 | 29759185 | |
| 133 | Ubiquitination | SGFHLPYKPKPPQET CEECCCCCCCCCCCC | 44.62 | 29967540 | |
| 135 | Ubiquitination | FHLPYKPKPPQETEK ECCCCCCCCCCCCCC | 66.24 | 29967540 | |
| 140 | Phosphorylation | KPKPPQETEKGHSAC CCCCCCCCCCCCCCC | 37.44 | 20860994 | |
| 184 | Phosphorylation | DRGEDVPSEEEEEEE HCCCCCCCHHHHHHH | 58.45 | 22167270 | |
| 201 | Phosphorylation | FEDRKDDSDDDGGGW CCCCCCCCCCCCCCC | 53.74 | 22167270 | |
| 210 | Phosphorylation | DDGGGWITPSNIKQI CCCCCCCCHHHHHHH | 17.73 | 23927012 | |
| 212 | Phosphorylation | GGGWITPSNIKQIQQ CCCCCCHHHHHHHHH | 42.40 | 23927012 | |
| 275 | Methylation | LRCHGCFKTTSDMSR HHHCCCCCCCCCHHH | 55.78 | 115974101 | |
| 275 | Ubiquitination | LRCHGCFKTTSDMSR HHHCCCCCCCCCHHH | 55.78 | - | |
| 286 | Phosphorylation | DMSRVFCSHCGNKTL CHHHHHHHHCCCCEE | 15.45 | - | |
| 291 | Ubiquitination | FCSHCGNKTLKKVSV HHHHCCCCEEEEEEE | 40.28 | 29967540 | |
| 292 | Phosphorylation | CSHCGNKTLKKVSVT HHHCCCCEEEEEEEE | 48.05 | - | |
| 294 | Ubiquitination | HCGNKTLKKVSVTVS HCCCCEEEEEEEEEC | 57.25 | - | |
| 295 | Ubiquitination | CGNKTLKKVSVTVSD CCCCEEEEEEEEECC | 42.74 | - | |
| 315 | Ubiquitination | MHFSRNPKVLNPRGL EEECCCCCCCCCCCC | 64.00 | 24816145 | |
| 315 | Acetylation | MHFSRNPKVLNPRGL EEECCCCCCCCCCCC | 64.00 | 25953088 | |
| 324 | Phosphorylation | LNPRGLRYSLPTPKG CCCCCCCCCCCCCCC | 21.43 | 28450419 | |
| 325 | Phosphorylation | NPRGLRYSLPTPKGG CCCCCCCCCCCCCCC | 22.80 | 25159151 | |
| 328 | Phosphorylation | GLRYSLPTPKGGKYA CCCCCCCCCCCCEEC | 42.81 | 26055452 | |
| 330 | Ubiquitination | RYSLPTPKGGKYAIN CCCCCCCCCCEECCC | 80.78 | 33845483 | |
| 333 | Ubiquitination | LPTPKGGKYAINPHL CCCCCCCEECCCCCC | 39.93 | 33845483 | |
| 333 | Acetylation | LPTPKGGKYAINPHL CCCCCCCEECCCCCC | 39.93 | 19608861 | |
| 334 | Phosphorylation | PTPKGGKYAINPHLT CCCCCCEECCCCCCC | 18.91 | 26074081 | |
| 341 | Phosphorylation | YAINPHLTEDQRFPQ ECCCCCCCCCCCCCH | 34.19 | 28152594 | |
| 343 | Ubiquitination | INPHLTEDQRFPQLR CCCCCCCCCCCCHHH | 39.45 | 21890473 | |
| 345 | Methylation | PHLTEDQRFPQLRLS CCCCCCCCCCHHHHH | 58.49 | 115485227 | |
| 352 | Phosphorylation | RFPQLRLSQKARQKT CCCHHHHHHHHHHHC | 24.17 | 23401153 | |
| 354 | Ubiquitination | PQLRLSQKARQKTNV CHHHHHHHHHHHCCC | 42.01 | 22817900 | |
| 358 | Ubiquitination | LSQKARQKTNVFAPD HHHHHHHHCCCCCCH | 36.19 | 21963094 | |
| 359 | Phosphorylation | SQKARQKTNVFAPDY HHHHHHHCCCCCCHH | 28.42 | 30257219 | |
| 366 | Phosphorylation | TNVFAPDYIAGVSPF CCCCCCHHHCCCCHH | 7.51 | 21552520 | |
| 368 | Ubiquitination | VFAPDYIAGVSPFVE CCCCHHHCCCCHHCC | 13.20 | 21890473 | |
| 371 | Phosphorylation | PDYIAGVSPFVENDI CHHHCCCCHHCCCCC | 16.23 | 28348404 | |
| 379 | Phosphorylation | PFVENDISSRSATLQ HHCCCCCCCCCEEEE | 23.67 | 28122231 | |
| 380 | Phosphorylation | FVENDISSRSATLQV HCCCCCCCCCEEEEE | 30.50 | 28122231 | |
| 382 | Phosphorylation | ENDISSRSATLQVRD CCCCCCCCEEEEEEC | 27.79 | 27251275 | |
| 384 | Phosphorylation | DISSRSATLQVRDST CCCCCCEEEEEECCC | 20.97 | 28857561 | |
| 390 | Phosphorylation | ATLQVRDSTLGAGRR EEEEEECCCCCCCCC | 18.24 | 28857561 | |
| 391 | Phosphorylation | TLQVRDSTLGAGRRR EEEEECCCCCCCCCC | 33.24 | 30257219 | |
| 396 | Methylation | DSTLGAGRRRLNPNA CCCCCCCCCCCCCCC | 21.73 | 115485221 | |
| 404 | Phosphorylation | RRLNPNASRKKFVKK CCCCCCCHHHHHHCC | 51.80 | 27251275 | |
| 410 | Ubiquitination | ASRKKFVKKR----- CHHHHHHCCC----- | 46.06 | 24816145 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 121 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NOB1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NOB1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| NOG2_HUMAN | GNL2 | physical | 26344197 | |
| TSR1_HUMAN | TSR1 | physical | 26344197 | |
| KLH22_HUMAN | KLHL22 | physical | 28514442 | |
| ANKH1_HUMAN | ANKHD1 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-333, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-184 AND SER-201, ANDMASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-184; SER-201 ANDSER-352, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-184, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-184 AND SER-201, ANDMASS SPECTROMETRY. | |